MBOT

Microbot Medical Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth 5/10
  • Momentum 3/10
Microbot Medical sales and earnings growth
MBOT Growth
Neutral
  • Revenue Y/Y 0.00%
  • EPS Y/Y 43.75%
  • FCF Y/Y -22.84%
Microbot Medical gross and profit margin trends
MBOT Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC -41.60%
Microbot Medical net debt vs free cash flow
MBOT Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage NA

Microbot Medical stock volatility is higher than the overall market. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗